表紙
市場調査レポート

世界の皮膚科市場

Global Dermatology Market 2013-2023

発行 GMR Data Ltd 商品コード 301552
出版日 ページ情報 英文 170 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.32円で換算しております。
Back to Top
世界の皮膚科市場 Global Dermatology Market 2013-2023
出版日: 2013年09月06日 ページ情報: 英文 170 Pages
概要

当レポートでは、世界の皮膚疾患治療薬の市場について調査分析し、皮膚疾患の各種区分、現在の治療法、新薬の研究開発の動向、市場規模の推移と予測、主要企業のプロファイルと取り組み、専門家の見解などをまとめ、概略下記の構成でお届けいたします。

第1章 エグゼクティブサマリー

第2章 皮膚病とその治療:イントロダクション

  • 人間の皮膚の構造と機能
  • 皮膚の状態と疾患
    • にきび(尋常性座瘡)
      • タイプと症状
      • 現在の治療法
    • 皮膚炎
      • タイプと症状
      • 現在の治療法
    • 乾癬
      • タイプと症状
      • 現在の治療法
    • 皮膚癌
      • タイプと症状
      • 現在の治療法
    • 皮膚感染
      • タイプと症状
      • 現在の治療法
    • 酒さ
      • タイプと症状
      • 現在の治療法
    • 脱毛症
      • タイプと症状
      • 現在の治療法

第3章 現在の動向と発展見通し

  • 現在の動向と発展見通し
  • 主要企業環境

第4章 皮膚治療薬の市場と予測

  • 世界のにきび市場
    • 主要動向・課題
    • 市場規模・予測
    • 主な薬剤・予測
    • 新たな開発
    • パイプライン将来分析
    • サマリー
  • 世界の乾癬市場
    • 主要動向・課題
    • 市場規模・予測
    • 生物製剤
    • パイプライン将来分析
    • サマリー
  • 世界のアトピー性皮膚炎市場
    • 主要動向・課題
    • 市場規模・予測
    • 生物製剤
    • パイプライン将来分析
    • サマリー
  • 世界の皮膚癌市場
    • 主要動向・課題
    • 市場規模・予測
    • 主な薬剤・予測
    • 新製品パイプライン
    • サマリー
  • 世界の皮膚感染市場
    • 主要動向・課題
    • 市場規模・予測
    • 主な薬剤・予測
    • 新製品パイプライン
  • 世界の酒さ市場
    • 主要動向・課題
    • 市場規模・予測
    • 主な薬剤
    • 新製品パイプライン
  • 世界の脱毛症市場
    • 主要動向・課題
    • 市場規模・予測
    • 生物製剤
    • パイプライン将来分析
    • サマリー

第5章 主要企業

  • Allergan, Inc
  • Bayer AG
  • Galderma
  • Valeant Pharmaceuticals International, Inc
  • Stiefel Laboratories, Inc
  • Novartis, Inc
  • Almirall, S.A
  • Derma Sciences
  • Hill Dermaceuticals, Inc
  • Biofrontera AG
  • Merck & Co. Inc
  • Merz Pharma Group
  • Laboratories Pierre Fabre

第6章 主要国市場の予測

  • 世界の見通し
  • 米国市場
  • 英国市場
  • フランス市場
  • ドイツ市場
  • スペイン市場
  • イタリア市場
  • 日本市場
  • その他の地域市場

第7章 専門家の見解

  • Klox Technologies Inc.
  • Global Rosacea Forum
  • Chin-Huai Keong博士

図表

目次
Product Code: GDS1

The Global Dermatology Market 2013-2023 covers the Pharmaceutical, Commercial, & Strategic Developments in Global Dermatology across the next decade. The report analyses how this important pharma sector will develop over the next ten years.

The report quantifies the market in terms of global size and breaks the market down into key leading countries with forecasts and analysis provided for each of these markets from 2013-2023. The report also examines the major drivers and restraints influencing the market over the next decade and explains the pharmaceutical developments within the market, analysing which companies will drive R&D in the Dermatology sectors.

GMR Data's The Global Dermatology Market 2013-2023 report details the prospects for this dynamic pharmaceutical sector with detailed forecasts from 2013-2023. The report will be valuable to those already involved in the dermatology market or to those wishing to enter this important market in the future.

The Global Dermatology Market 2013-2023 report includes 170 pages, which include over 160 tables, charts and graphs quantifying and forecasting the market in detail. In addition, the report offers profiles of the 13 leading companies in the dermatology market, alongside 3 interviews with;

  • Cutting edge R&D company; KLOX Technologies Inc of Canada
  • Highly experienced dermatology doctor; Dr Keong of Garden Clinic Haroo, Tokyo
  • And the world's largest rosacea forum; the Global Rosacea Forum.

These 3 interviews offer an expert insight into the direction of the dermatology sector, across the next decade, which underpins the detailed analysis and forecast areas.

Table of Contents

Chapter 1 Executive Summary

  • 1.1. Dermatological Drugs Market Review
  • 1.2. Chapter Breakdown
  • 1.3. Research and Analysis Methods

Chapter 2 Introduction to Dermatological Diseases and Treatments

  • 2.1 Structure and Function of Human Skin
  • 2.2 Dermatological Conditions & Skin disorders
    • 2.2.1 Acne (Acne Vulgaris)
      • 2.2.1.1 Types & Symptoms of Acne
      • 2.2.1.2 Current Treatments for Acne
    • 2.2.2 Dermatitis
      • 2.2.2.1 Types & Symptoms of Dermatitis
      • 2.2.2.2 Current Treatments for Dermatitis
    • 2.2.3 Psoriasis
      • 2.2.3.1 Types & Symptoms of Psoriasis
      • 2.2.3.2 Current Treatments for Psoriasis
    • 2.2.4 Skin Cancer
      • 2.2.4.1 Types & Symptoms of Skin Cancer
      • 2.2.4.2 Current Treatments for Skin Cancer
    • 2.2.5 Skin Infections
      • 2.2.5.1 Types & Symptoms of Skin Infections
      • 2.2.5.2 Current Treatments for Skin Infections
    • 2.2.6 Rosacea
      • 2.2.6.1 Types & Symptoms of Rosacea
      • 2.2.6.2 Current Treatments for Rosacea
    • 2.2.7 Alopecia
      • 2.2.7.1 Types & Symptoms of Alopecia
      • 2.2.7.2 Current Treatments for Alopecia

Chapter 3 Current Trends & Developments in the Dermatology Market 2013-2023

  • 3.1 Current Trends & Development
  • 3.2 Major Players - Landscape

Chapter 4 Dermatological Drugs Market & Forecast

  • 4.1 Global Acne Market - 2013 -2023
    • 4.1.1 Major Trends & Issues
    • 4.1.2 Market Size & Forecast
    • 4.1.3 Major Drugs & Forecast
    • 4.1.4 New Developments
    • 4.1.5 Future Pipeline Analysis
    • 4.1.6 The World Acne Drug Market - Summary
  • 4.2 Global Psoriasis Market - 2013 -2023
    • 4.2.1 Major Trends & Issues
    • 4.2.2 Market Size & Forecast
    • 4.2.3 Biologics
    • 4.2.4 Future Pipeline Analysis
    • 4.2.5 The World Psoriasis Drug Market - Summary
  • 4.3 Global Atopic Dermatitis Market - 2013 -202
    • 4.3.1 Major Trends & Issues
    • 4.3.2 Market Size & Forecast
    • 4.3.3 Biologics
    • 4.3.4 Future Pipeline Analysis
    • 4.3.5 The World Atopic Dermatitis Drug Market - Summary
  • 4.4 Global Skin Cancer Market - 2013 -2023
    • 4.4.1 Major Trends & Issues
    • 4.4.2 Market Size & Forecast
    • 4.4.3 Major Drugs & Forecast
    • 4.4.4 New Product Pipeline
    • 4.4.5 The World Skin Cancer Drug Market - Summary
  • 4.5 Global Skin Infections Market - 2013 -2023
    • 4.5.1 Major Trends & Issues
    • 4.5.2 Market Size & Forecast
    • 4.5.3 Major Drugs & Forecast
    • 4.5.4 New Product Pipeline
  • 4.6 Global Rosacea Market - 2013 -2023
    • 4.6.1 Major Trends & Issues
    • 4.6.2 Market Size & Forecast
    • 4.6.3 Major Drugs
    • 4.6.4 New Product Pipeline
  • 4.7 Global Alopecia Market - 2013 -2023
    • 4.7.1 Major Trends & Issues
    • 4.7.2 Market Size & Forecast
    • 4.7.3 Biologics
    • 4.7.4 Future Drug Pipeline Analysis
    • 4.7.5 The World Alopecia Drug Market - Summary

Chapter 5 Leading Companies in the Global Dermatological Market

  • 5.1 Allergan, Inc
  • 5.2 Bayer AG
  • 5.3 Galderma
  • 5.4 Valeant Pharmaceuticals International, Inc
  • 5.5 Stiefel Laboratories, Inc
  • 5.6 Novartis, Inc
  • 5.7 Almirall, S.A
  • 5.8 Derma Sciences
  • 5.9 Hill Dermaceuticals, Inc
  • 5.10 Biofrontera AG
  • 5.11 Merck & Co. Inc
  • 5.12 Merz Pharma Group
  • 5.13 Laboratories Pierre Fabre

Chapter 6 Key National Markets in the Global Dermatology Sector 2013-2023

  • 6.1 Global Outlook 2013-2023
  • 6.2 The US Dermatology Market 2013-2023
  • 6.3 The UK Dermatology Market 2013-2023
  • 6.4 The French Dermatology Market 2013-2023
  • 6.5 The German Dermatology Market 2013-2023
  • 6.6 The Spanish Dermatology Market 2013-2023
  • 6.7 The Italian Dermatology Market 2013-2023
  • 6.8 The Japanese Dermatology Market 2013-2023
  • 6.9 The Rest of the World Dermatology Market 2013-2023

Chapter 7 Expert Opinion

  • 7.1 Klox Technologies Inc.
  • 7.2 Global Rosacea Forum
  • 7.3 Dr. Chin-Huai Keong

List of Tables

  • Table 2.2.1 Acne Type & Symptoms
  • Table 2.2.2 Dermatitis Types & Symptoms
  • Table 2.2.2.1.a Major drugs for Dermatitis in the Market
  • Table 2.2.2.2.a Dermatitis Drug Pipeline
  • Table 2.2.3.1 Psoriasis Types & Symptoms
  • Table2.2.3.1.a Prevalence of Psoriasis in Selected Countries Worldwide 2013
  • Table 2.2.3.3.a Psoriasis Phase 3 Drugs Pipeline
  • Table 2.2.3.3.b Psoriasis Phase 2 Drugs Pipeline
  • Table 2.2.4 Skin Cancer Types & Symptoms
  • Table 2.2.4.1 Skin Cancer Types & Symptoms
  • Table 2.2.4.3 Skin Cancer Types & Symptoms
  • Table 2.2.5.a Bacterial Infection Types & Symptoms
  • Table 2.2.5.b Viral Infection Types & Symptoms
  • Table 2.2.5.c Fungal Infection Types & Symptoms
  • Table 2.2.5.d Parasitic Infection Types & Symptoms
  • Table 2.2.5.1 Major Drugs for Skin Infection in the Market
  • Table 2.2.5.3 Skin Infection Drug Pipeline
  • Table 2.2.6.1 Skin Infection Drug Pipeline
  • Table 2.2.7: Alopecia Types & Symptoms
  • Table 2.2.7.1 Major Drugs for Alopecia
  • Table 2.2.7.2 Alopecia Drugs Pipeline
  • Table 3.2.1 Merger & Acquisitions
  • Table 4.a Market Size & Forecast - Global Dermatological Drugs
  • Table 4.b Global Dermatological Drug Market Forecast ($/bn, P/A, CAGR)
  • Table 4.1.2.a Market Size & Forecast - Acne Market ($/m, P/A, CAGR)
  • Table 4.1.2.b Acne Drugs Market Share - By Revenue ($/bn, P/A, CAGR)
  • Table 4.1.3.1 Market Forecast for Solodyn ($/m, P/A, CAGR)
  • Table 4.1.3.2 Market Forecast for Isotretinoin ($/m, P/A, CAGR)
  • Table 4.1.3.3 Market Forecast for Doryx ($/m, P/A, CAGR)
  • Table 4.1.3.4 Market Forecast for Diane ($/m, P/A, CAGR)
  • Table 4.1.3.5 Market Forecast for Ziana ($/m, P/A, CAGR)
  • Table 4.1.4.1 Acne Drugs R&D Pipeline 2013
  • Table 4.2.2.a Market Size & Forecast - Psoriasis Market ($/m, P/A, CAGR)
  • Table 4.2.3.1 Total Enbrel Sales 2010, 2011 & 2012 ($/m, CAGR)
  • Table 4.2.3.2 Enbrel Forecasting for Psoriatic Treatment ($/m, P/A, CAGR)
  • Table 4.2.3.3 Total Humira Sales 2010, 2011 & 2012 ($/m, CAGR)
  • Table 4.2.3.4 Humira Forecasting for Psoriatic Treatment ($/m, P/A, CAGR)
  • Table 4.2.3.5 Total Remicade Sales 2010, 2011 & 2012 ($/m, CAGR)
  • Table 4.2.3.5 Total Stelara Sales 2010, 2011 & 2012 ($/m, CAGR)
  • Table 4.2.3.6 Total Simponi Sales 2010, 2011 & 2012 ($/m, CAGR)
  • Table 4.3.2.1 Market Size & Forecast for Atopic Dermatitis ($/m, P/A, CAGR)
  • Table 4.3.3.1 Revenue of Protopic ($/m, P/A, CAGR)
  • Table 4.3.3.2 Market Size & Forecast for Protopic ($/m, P/A, CAGR)
  • Table 4.4.2.4 Revenue for Elidel ($/m, P/A, CAGR)
  • Table 4.3.3.3 Market Size & Forecast for Elidel ($/m, P/A, CAGR)
  • Table 4.3.3.4 Revenue for Clobex ($/m, P/A, CAGR)
  • Table 4.3.3.5 Market Size & Forecast for Clobex ($/m, P/A, CAGR)
  • Table 4.3.3.6 Revenue for Elocon ($/m, P/A, CAGR)
  • Table 4.3.3.7 Market Size & Forecast for Elocon ($/m, P/A, CAGR)
  • Table 4.4.2.1 Market Size & Forecast for Melanoma Skin Cancer ($/bn, P/A, CAGR)
  • Table 4.4.2.2 Revenue of Yervoy ($/m, P/A, CAGR)
  • Table 4.4.2.3 Market Size & Forecast for Yervoy ($/m, P/A, CAGR)
  • Table 4.4.2.4 Revenue of Zelboraf ($/m, P/A, CAGR)
  • Table 4.4.2.5 Market Size & Forecast for Zelboraf ($/m, P/A, CAGR)
  • Table 4.5.2.1 Market Size & Forecast for Skin and Skin Structure Infections ($/bn, P/A, CAGR)
  • Table 4.5.2.2 Market Size & Forecast for Herpes ($/bn, P/A, CAGR)
  • Table 4.5.3.1 Revenue of Zyvox ($/m, P/A, CAGR)
  • Table 4.5.3.2 Market Size & Forecast for Zyvox ($/m, P/A, CAGR)
  • Table 4.5.3.3 Revenue for Cubicin ($/m, P/A, CAGR)
  • Table 4.5.3.4 Market Size & Forecast for Cubicin ($/m, P/A, CAGR)
  • Table 4.5.3.5 Revenue for Zovirax ($/m, P/A, CAGR)
  • Table 4.5.3.6 Market Size & Forecast for Zovirax ($/m, P/A, CAGR)
  • Table 4.5.3.7 Revenue for Valtrex ($/m, P/A, CAGR)
  • Table 4.5.3.8 Market Size & Forecast for Valtrex ($/m, P/A, CAGR)
  • Table 4.5.3.9 Revenue for Zostavax ($/m, P/A, CAGR)
  • Table 4.5.3.10 Market Size & Forecast for Zostavax ($/m, P/A, CAGR)
  • Table 4.6.2.1 Market Size & Forecast - Rosacea Market ($/bn, P/A, CAGR)
  • Table 4.6.3.1 Major Drugs - Rosacea Market ($/bn, P/A, CAGR)
  • Table 4.6.3.2 Oracea Forecasting for Rosacea Treatment ($/m, P/A, CAGR)
  • Table 4.6.4.1 New Product Pipeline for Rosacea Treatment
  • Table 4.7.2.1 Market Size & Forecast for Alopecia ($/bn P/A, CAGR)
  • Table 4.7.3.1 Revenue of Propecia ($/m, P/A, CAGR)
  • Table 4.7.3.2 Market Size & Forecast for Propecia ($/m, P/A, CAGR)
  • Table 4.7.3.3 Market Size & Forecast for Rogaine ($/m, P/A, CAGR)
  • Table 5.1.1 Allergan Products Overview
  • Table 5.1.2 Allergan R&D Pipeline in the Dermatology Segment - 2012
  • Table 5.2.1 Bayer's Key Dermatology Products 2013
  • Table 5.2.2 Bayer's R&D Pipeline - 2013
  • Table 5.3.1 Galderma Key Dermatology Products 2013
  • Table 5.4.1 Valeant Key Dermatology Products 2013
  • Table 5.4.2 Valeant's R&D Pipeline
  • Table 5.5.1 Stiefel's Products Overview 2013
  • Table 5.5.2 Stiefel R&D Pipeline in the Dermatology Segment - 2013
  • Table 5.6.1 Novartis (Fougera) Products Overview
  • Table 5.6.2 Novartis R&D Pipeline in the Dermatology Segment - 2013
  • Table 5.7.1 Almirall Products Overview
  • Table 5.7.2 Almirall R&D Pipeline in the Dermatology Segment - 2013
  • Table 5.9.1 Hill Products Overview
  • Table 5.10.1 Biofrontera Product Overview
  • Table 5.10.2 Biofrontera Drug Pipeline
  • Table 5.11.1 Merck & Co, Inc Product Overview
  • Table 5.11.2 Merck & Co, Inc Drug Pipeline
  • Table 5.12.1 Merz Product Overview
  • Table 5.13.1 Pierre Fabre Product Overview
  • Table 6.0.1 The Global Dermatology Market Forecast 2011 -2023, by Country ($/bn, P/A, CAGR)
  • Table 6.0.2 Key Countries CAGR 2013-2023 (%)
  • Table 6.0.3 Estimated Dermatological Market Share for Selected Countries 2013, 2018 and 2023 (%)
  • Table 6.0.7 Total Healthcare Expenditure per Capita 2011, Sample countries ($/p/a)
  • Table 6.1.1 The US Dermatology Market Forecast 2011-2023 ($/bn, P/A, CAGR, %)
  • Table 6.2.1 The UK Dermatology Market Forecast 2011-2023 ($/bn, P/A, CAGR, %)
  • Table 6.3.1 The French Dermatology Market Forecast 2011-2023 ($/bn, P/A, CAGR, %)
  • Table 6.4.1 The German Dermatology Market Forecast 2011-2023 ($/bn, P/A, CAGR, %)
  • Table 6.5.1 The Spanish Dermatology Market Forecast 2011-2023 ($/bn, P/A, CAGR, %)
  • Table 6.6.1 The Italian Dermatology Market Forecast 2011-2023 ($/bn, P/A, CAGR, %)
  • Table 6.7.1 The Japanese Dermatology Market Forecast 2011-2023 ($/bn, P/A, CAGR, %)
  • Table 6.8.1 The ROW Dermatology Market Forecast 2011-2023 ($/bn, P/A, CAGR, %)
  • Table 6.8.3 BRIC Population, GDP 2000 & 2010, CAGR & GDP per Capita 2000 & 2010 ($)
  • Table 6.8.4 Galderma & Novartis Global HQ, R&D and Manufacturing Sites

List of Figures

  • Figure 2.2.3.1 Breakdown by Type , Psoriasis
  • Figure 2.2.4.1 Global Market Size as per Skin Cancer Type - Incidences
  • Figure 4.a Global Dermatological Drug Market Growth
  • Figure 4.b Global Dermatological Drug Market Share - By Revenue
  • Figure 4.1.2.a Acne Market Growth
  • Figure 4.1.2.b. Acne Drugs Market Share - By Revenue
  • Figure 4.1.3.1 Solodyn Market Growth
  • Figure 4.1.3.2 Isotretinoin Market Growth
  • Figure 4.1.3.3 Doryx Market Growth
  • Figure 4.1.3.4 Diane Market Growth
  • Figure 4.1.3.5 Ziana Market Growth
  • Figure 4.2.2.a Psoriasis Market Growth
  • Figure 4.2.2.b Overall Psoriatic therapeutic market - Growth from 2012 to 2013
  • Figure 4.2.3.1 Enbrel Market Growth
  • Figure 4.2.3.2 Humira Market Growth
  • Figure 4.3.2.1 Atopic Dermatitis Market Growth
  • Figure 4.3.3.1 Protopic Market Value
  • Figure 4.3.3.2 Elidel Market Growth
  • Figure 4.3.3.3 Clobex Market Growth
  • Figure 4.3.3.4 Elocon Market Growth
  • Figure 4.4.2.1 Melanoma Skin Cancer Market Growth
  • Figure 4.4.2.2 Yervoy Market Growth
  • Figure 4.4.2.3 Zelboraf Market Growth
  • Figure 4.5.2.1 Skin & Skin Structure Infections Market
  • Figure 4.5.2.2 Herpes Market
  • Figure 4.5.3.1 Zyvox Market Growth
  • Figure 4.5.3.2 Cubicin Market Growth
  • Figure 4.5.3.3 Zovirax Market Growth
  • Figure 4.5.3.4 Valtrex Market Growth
  • Figure 4.5.3.5 Zostavax Market Growth
  • Figure 4.6.2.a Zostavax Market Growth
  • Figure 4.6.3.1 Rosacea Market Growth
  • Figure 4.6.3.2 Oracea Market Growth
  • Figure 4.7.2.1 Alopecia Market Growth
  • Figure 4.7.3.1 Propecia Market Growth
  • Figure 4.7.3.2 Rogaine Market Growth
  • Figure 6.0.4 Global Market Share for Selected Countries 2013
  • Figure 6.0.5 Global Market Share for Selected Countries 2018
  • Figure 6.o.6 Global Market Share for Selected Countries 2023
  • Figure 6.1.2 The US Dermatology Market Forecast 2011-2023 ($/bn)
  • Figure 6.2.2 The UK Dermatology Market Forecast Figure 2011-2023 ($/bn)
  • Figure 6.3.2 The French Dermatology Market Forecast 2011-2023 ($/bn)
  • Figure 6.4.2 The German Dermatology Market Forecast 2011-2023 ($/bn)
  • Figure 6.5.2 The Spanish Dermatology Market Forecast 2011-2023 ($/bn)
  • Figure 6.6.2 The Italian Dermatology Market Forecast 2011-2023 ($/bn)
  • Figure 6.7.2 The Japanese Dermatology Market Forecast 2011-2023 ($/bn)
  • Table 6.8.2 The ROW Dermatology Market Forecast 2011-2023 ($/bn)
Back to Top